AVAH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Aveanna Healthcare Holdings Inc (AVAH) is not a strong buy at this moment for a beginner investor seeking long-term opportunities. While the company has shown revenue growth, its declining net income and EPS, coupled with insider selling and lack of strong trading signals, make it less appealing. Additionally, the upcoming earnings announcement on March 19, 2026, introduces uncertainty, and the stock's technical indicators do not suggest a clear upward trend.
The MACD is positive and expanding, suggesting slight bullish momentum. However, RSI is neutral at 40.65, and moving averages are converging, indicating no strong trend. The stock is trading near its pivot level (7.269), with key resistance at 7.464 and support at 7.075. Overall, the technical indicators do not provide a clear buy signal.
Gross margin also improved by 4.28% YoY. An upcoming earnings announcement on March 19, 2026, could provide more clarity on the company's performance.
Insiders have been selling shares, with a significant increase of 675.38% in the last month. The stock has a 90% chance of declining by -5.78% in the next month based on historical patterns.
In Q3 2025, revenue increased to $621.94M, up 22.18% YoY. However, net income dropped to $14.06M (-132.83% YoY), and EPS fell to 0.06 (-127.27% YoY). Gross margin improved to 32.19% (+4.28% YoY), but overall profitability metrics are declining.
No recent analyst ratings or price target changes were provided. Wall Street sentiment is unclear, but the lack of positive momentum and insider selling suggests a cautious stance.
